Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein (2024)
- Authors:
- Silva, Mariângela de Oliveira
- Castro-Amarante, Maria Fernanda
- Carvalho, Alexia Adrianne Venceslau Brito
- Almeida, Bianca da Silva
- Daher, Isabela Pazotti
- Souza-Silva, Guilherme Antonio de
- Yamamoto, Marcio Massao
- Koike, Gabriela
- Souza, Edmarcia Elisa de
- Wrenger, Carsten
- Ferreira, Luis Carlos de Souza
- Boscardin, Silvia Beatriz
- Silva, Mariângela de Oliveira
- USP affiliated authors: YAMAMOTO, MARCIO MASSAO - ICB ; WRENGER, CARSTEN - ICB ; FERREIRA, LUIS CARLOS DE SOUZA - ICB ; BOSCARDIN, SILVIA BEATRIZ - ICB ; SILVA, MARIÂNGELA DE OLIVEIRA - ICB ; AMARANTE, MARIA FERNANDA DE CASTRO - ICB ; CARVALHO, ALEXIA ADRIANNE VENCESLAU BRITO - ICB ; ALMEIDA, BIANCA DA SILVA - ICB ; DAHER, ISABELA PAZOTTI - FM ; SILVA, GUILHERME ANTONIO DE SOUZA - ICB ; KOIKE, GABRIELA - ICB ; SOUZA, EDMARCIA ELISA DE - ICB
- Unidades: ICB; FM
- DOI: 10.3390/vaccines12040356
- Subjects: PARASITOLOGIA; MICROBIOLOGIA; PROTEÍNAS RECOMBINANTES; PROTEÍNAS SANGUÍNEAS; ANTICORPOS; IMUNOGENICIDADE DA VACINA; IMUNOGENÉTICA; IMUNOGLOBULINAS; COVID-19; VACINAS VIRAIS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
SILVA, Mariângela de Oliveira et al. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12040356. Acesso em: 31 mar. 2026. -
APA
Silva, M. de O., Castro-Amarante, M. F., Carvalho, A. A. V. B., Almeida, B. da S., Daher, I. P., Souza-Silva, G. A. de, et al. (2024). Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, 12( 4), 14 . doi:10.3390/vaccines12040356 -
NLM
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2026 mar. 31 ] Available from: https://doi.org/10.3390/vaccines12040356 -
Vancouver
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2026 mar. 31 ] Available from: https://doi.org/10.3390/vaccines12040356 - Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine
- Targeting the non-structural protein 1 from dengue virus to a dendritic cell population confers protective immunity to lethal virus challenge
- A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses
- Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants
- Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation
- Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines
- Reactivity of DENV-positive sera against recombinant envelope proteins produced in bacteria and eukaryotic cells
- STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cells
- Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells
- Type 1 and 2 mouse spleen conventional dendritic cells differentially prime T helper cells after antigen targeting via DEC205 and DCIR2 receptors
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
